Added to YB: 2024-02-13
Pitch date: 2024-02-13
TARA:US [bullish]
Protara Therapeutics, Inc.
+148.26%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
Market Cap
$348.9M
Pitch Price
$2.88
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.77
P/E
-4.70
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Protara Therapeutics, Inc. TARA:US
A summary for this pitch has not been created yet.
Read full article (0 min)